Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — you should not take two doses of Wegovy at once, or double up to compensate for a missed injection. Wegovy (semaglutide) is a once-weekly prescription medicine with a fixed schedule set by your prescriber, and taking more than your prescribed dose increases the risk of serious side effects without any benefit to weight loss. If you have missed a dose or are unsure about your schedule, the right move is to check the Patient Information Leaflet that came with your pen and contact your prescribing team. These are prescription-only medicines that require a clinical assessment before use, and decisions about dosing always sit with a qualified prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The once-weekly rule for Wegovy is not arbitrary. Semaglutide has a half-life of roughly one week, which means the medicine stays active in your body for considerably longer than a daily tablet would. Doubling up does not give you twice the effect, it stacks two active doses on top of each other, pushing the concentration in your system well above what your prescriber intended.
The consequences are practical. At normal doses, the most common side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and reflux. These are dose-related, meaning they tend to be worse when the amount of semaglutide in your system is higher than your body has adjusted to. Taking two doses compounds exactly that risk.
The NHS semaglutide medicines page is clear that Wegovy is taken once a week and that if you miss a dose, you should check the leaflet rather than automatically replacing it. If more than five days have passed since the missed injection was due, you skip it and resume on your next scheduled day. If fewer than five days have passed, taking the missed dose is generally acceptable, but that guidance comes from the leaflet, not from a self-made decision to take two pens close together.
The detail of your specific situation (which dose you are on, how long you have been on it, any symptoms you have had) is exactly what your prescriber needs to know before advising you, and if you are wondering whether taking two doses of 0.25mg Wegovy is ever appropriate, there is specific guidance available on that question. There is no safe shortcut around that conversation.
It does not. This is one of the questions our prescribers hear fairly regularly, and the answer is consistent: semaglutide's effect on appetite and body weight is driven by sustained receptor activity over time, not by momentary peaks in blood concentration. The dose titration schedule (starting low and increasing gradually every four weeks) exists precisely because the therapeutic benefit builds steadily, while the side-effect risk is tied to how quickly the dose rises.
You can read about the full Wegovy dose schedule and what each level is intended to do, but the short version is this: the starter doses (0.25mg and 0.5mg) are there to let your body adjust, not to produce the maximum effect. Jumping ahead by taking extra pens bypasses that buffer entirely.
The evidence base for Wegovy is built on the licensed schedule. In the STEP 1 trial, published in the New England Journal of Medicine, participants following the prescribed titration saw an average weight reduction of around 15% over 68 weeks. That result was not achieved by taking more, it was achieved by staying on the protocol consistently.
If your weight loss has slowed or stopped at your current dose, that is worth discussing with your prescriber. A planned dose increase, done at the right time, is the appropriate route, not a doubled dose taken unilaterally.
Missed it entirely? Open the leaflet first. The rule is straightforward: within five days of when the dose was due, you can take it; beyond that, skip it and carry on with your usual weekly day. Do not change your next scheduled injection to compensate either way. If you are unsure which situation applies to you, the one-minute check is this, look at the date on your previous pen and count the days since you injected it. That single piece of information tells you exactly which path the leaflet recommends.
Taken two doses by accident? Do not inject again until you are certain it is safe to do so. Contact your prescribing team or pharmacist promptly. If you experience severe nausea, vomiting, or stomach pain following a double dose, seek medical advice. For questions about what happens if you take two doses of Wegovy, there is more detail available, but in any acute situation your prescriber or 111 is the right first call.
If you have been considering a lower dose because the current one is proving difficult to tolerate, that too is a prescriber conversation, there is guidance available on adjusting to a lower Wegovy dose if side effects are the reason you are thinking about changing things. The correct technique and timing for each Wegovy dose also matters more than many people realise, and is worth reviewing if any part of your injection routine feels uncertain.
Wegovy is a prescription-only medicine, which means a qualified clinician is responsible for your dosing decisions throughout treatment, not just at the start. That includes reviewing whether your current dose is working, whether a planned increase is appropriate, and what to do when things do not go to plan. That structure is not bureaucracy; it is the safety mechanism that makes a medicine like this appropriate for long-term use.
For context on what private treatment involves and what it costs, the Wegovy price comparison page covers the UK market honestly, including what to look for beyond the headline figure. If you are weighing up your options more broadly, the treatment overview sets out what is available and how the different approaches compare.
The clinical team at nume reviews every consultation personally. There are no algorithms making dosing decisions here, a GPhC-registered prescriber reads your answers the same day, including any questions about your current schedule or a dose you are uncertain about. If you are ready to check whether Wegovy is clinically appropriate for you, check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.